Israeli Ministry Of Health Approves Can-Fite Biopharma's Phase 2A Clinical Trial With Orally-administered Namodenoson In The Treatment Of Pancreatic Carcinoma, Study Will Aim To Establish Safety And Clinical Efficacy
Author: Benzinga Newsdesk | September 16, 2024 07:09am